tiprankstipranks
Instil Bio, Inc. (TIL)
NASDAQ:TIL
US Market
TIL
Instil Bio
RESEARCH TOOLSreports
Want to see TIL full AI Analyst Report?

Instil Bio (TIL) Stock News & Sentiment

374 Followers
Instil Bio Faces Heightened Cybersecurity Threats as Data Breach Risks Jeopardize Clinical Trials and Long-Term Strategy
Premium
Company Announcements
Instil Bio Faces Heightened Cybersecurity Threats as Data Breach Risks Jeopardize Clinical Trials and Long-Term Strategy
2M ago
TIL
Instil Bio, Inc. (TIL) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Instil Bio, Inc. (TIL) Q4 Earnings Cheat Sheet
2M ago
TIL
Instil Bio Ends Key Oncology Licensing Agreement with ImmuneOnco
Premium
Company Announcements
Instil Bio Ends Key Oncology Licensing Agreement with ImmuneOnco
4M ago
8K
TIL
Instil Bio’s AXN-2510 Study: A Promising Step in Cancer Treatment
Premium
Company Announcements
Instil Bio’s AXN-2510 Study: A Promising Step in Cancer Treatment
7M ago
TIL
Instil Bio’s AXN-2510: Promising Data and Valuation Gap Justify Buy Rating
Premium
Ratings
Instil Bio’s AXN-2510: Promising Data and Valuation Gap Justify Buy Rating
8M ago
TIL
Instil Bio’s Promising Outlook: Buy Rating Supported by Successful Trials and Market Potential
Premium
Ratings
Instil Bio’s Promising Outlook: Buy Rating Supported by Successful Trials and Market Potential
9M ago
TIL
Instil Bio Receives Buy Rating Amid Promising Trial Data and Strong Financial Outlook
Premium
Ratings
Instil Bio Receives Buy Rating Amid Promising Trial Data and Strong Financial Outlook
9M ago
TIL
More TIL News >

TIL News on the Web

Is Instil Bio (TIL) Attractively Priced After Q1 2026? EPS -$0.62 vs est. -$0. ...
GuruFocus News
Bearish
Instil Bio Faces Heightened Cybersecurity Threats as Data Breach Risks Jeopardize Clinical Trials and Long-Term Strategy
TipRanks News
Bearish
Instil Bio, Inc. (TIL) Q4 Earnings Cheat Sheet
TipRanks News
Bearish
Instil Bio downgraded to Neutral from Buy at H.C. Wainwright
TipRanks News
Bearish
Instil Bio (TIL) was downgraded to a Hold Rating at H.C. Wainwright
TipRanks News
Bearish
TIL Announces Termination of AXN-2510 Clinical Program—All Rights Revert to ImmuneOnco
Market Chameleon
Neutral
Instil Bio Ends Key Oncology Licensing Agreement with ImmuneOnco
TipRanks News
Bearish
Instil Bio shares slide on discontinuation of lead clinical programs
Proactive Investors
Bearish

News Score - Last 7 Days

Very Negative
TIL
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week0%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TIL’s Media Buzz Sentiment?
Currently, no data Available
What is TIL’s weekly average amount of articles?
Currently, no data Available
What is TIL’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TVTXTravere Therapeutics
HVOOpen Orphan Plc
PBMPsyence Biomedical
QDELQuidelOrtho
Showing the stocks with the most bullish news sentiment over the past week